{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:09:01Z","timestamp":1775624941197,"version":"3.50.1"},"reference-count":32,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Drug-resistant tuberculosis remains a major challenge in resource-limited settings, particularly in rural regions of the Eastern Cape Province, where limited laboratory infrastructure, constrained access to advanced molecular diagnostics, shortages of specialized healthcare personnel, and prolonged diagnostic turnaround times can delay appropriate treatment initiation. This study examined whether routinely detectable genomic resistance markers could be integrated with parsimonious machine learning approaches to support early risk stratification for isoniazid (INH) and\/or rifampicin (RIF) resistance and multidrug-resistant tuberculosis (MDR-TB). Methods: We conducted a retrospective analysis of clinical, demographic, and genomic data from 207 Mycobacterium tuberculosis isolates representing 207 unique patients. Resistance was classified as INH and\/or RIF resistance or MDR-TB (concurrent resistance to both drugs). Predictors included age, sex, and canonical resistance-associated mutations (katG S315T, inhA \u221215C&gt;T, and rpoB codon substitutions). Logistic regression was used to estimate adjusted odds ratios (aORs), while Random Forest models were applied to assess non-linear feature importance. Internal validation was performed using 10-fold cross-validation. A systems network analysis mapped the integration of model-derived risk bands into Clinical Governance structures and Community-Engaged Education pathways, including interventions delivered by Community Health Workers (CHWs). Results: INH and\/or RIF resistance was identified in 58.9% of isolates, with 21.7% classified as MDR-TB. The most frequently detected mutations were katG S315T (29.0%) and rpoB S450L (26.6%). Logistic regression identified rpoB S450L (aOR 4.20; 95% CI: 2.10\u20138.45) and katG S315T (aOR 2.85; 95% CI: 1.40\u20135.80) as the strongest independent predictors, while age and sex were not statistically significant. Models demonstrated strong internal discrimination (AUCs of 0.96 for INH and\/or RIF resistance and 0.99 for MDR-TB). Risk stratification categorized 18% of patients as high risk. Scenario-based modelling suggested that prioritizing high-risk patients for reflex Line Probe Assay testing could reduce the median time to appropriate treatment from 14 to 3 days and may reduce progression from isoniazid-resistant TB to MDR-TB under specified operational assumptions. Conclusions: Mutation-informed predictive modelling demonstrates strong internally validated discrimination and provides a structured framework for risk-stratified intervention. Integrating probability-based risk thresholds within Clinical Governance systems and community-level support structures, including CHW-led adherence and education strategies, may support earlier treatment optimization in high-burden rural settings. External validation and prospective implementation studies are required before broader programmatic adoption.<\/jats:p>","DOI":"10.3390\/diseases14040132","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:19:32Z","timestamp":1775434772000},"page":"132","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive Analysis of Drug-Resistant Tuberculosis: Integrating Molecular Markers, Clinical Governance, and Community-Engaged Education in Rural South Africa"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5417-6601","authenticated-orcid":false,"given":"Siphosihle","family":"Conham","sequence":"first","affiliation":[{"name":"WSU\u2014TB Research Group, School of Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X1, Mthatha 5100, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ncomeka","family":"Sineke","sequence":"additional","affiliation":[{"name":"WSU\u2014TB Research Group, School of Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X1, Mthatha 5100, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ntandazo","family":"Dlatu","sequence":"additional","affiliation":[{"name":"Walter Sisulu Institute for Clinical Governance, Healthcare Administration, School of Public Health, Faculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha 5099, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindiwe Modest","family":"Faye","sequence":"additional","affiliation":[{"name":"WSU\u2014TB Research Group, School of Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X1, Mthatha 5100, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0388-787X","authenticated-orcid":false,"given":"Mojisola Clara","family":"Hosu","sequence":"additional","affiliation":[{"name":"WSU\u2014TB Research Group, School of Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X1, Mthatha 5100, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-3864","authenticated-orcid":false,"given":"Teke","family":"Apalata","sequence":"additional","affiliation":[{"name":"WSU\u2014TB Research Group, School of Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X1, Mthatha 5100, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Liebenberg, D., Gordhan, B.G., and Kana, B.D. (2022). Drug-resistant tuberculosis: Implications for transmission, diagnosis, and disease management. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.943545"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Elbehiry, A., Marzouk, E., Edrees, H.M., AlShaqi, R., Ellethy, A.T., Alzaben, F., Anagreyyah, S., Algarni, A., Almuhaydili, K., and Alotaibi, I. (2025). Advancing the fight against tuberculosis: Integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1596579"},{"key":"ref_3","unstructured":"World Health Organization (2025). Global Tuberculosis Report 2025, WHO."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40249-021-00840-5","article-title":"Identifying contextual determinants of problems in tuberculosis care provision in South Africa: A theory-generating case study","volume":"10","author":"Murdoch","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Holtgrewe, L.M.L., Johnson, A., Nyhan, K., Boffa, J., Shenoi, S.V., Karat, A.S., Davis, J.L., and Charalambous, S. (2024). Burden of tuberculosis in underserved populations in South Africa: A systematic review and meta-analysis. PLoS Glob. Public Health, 4.","DOI":"10.1371\/journal.pgph.0003753"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, S., Mensah, E., Liu, M., Pan, L., Lu, W., Zhou, S., Zhang, L., Cheng, Y., Zhao, H., and Wei, S. (2025). The burden of tuberculosis and drug resistance in 22 Sub-Saharan African countries, 1990\u20132021. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1695592"},{"key":"ref_7","first-page":"e02400-24","article-title":"Mutations associated with resistance to rifampicin and isoniazid identified in strains of the Mycobacterium tuberculosis complex","volume":"13","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Traor\u00e9, A.N., Rikhotso, M.C., Mphaphuli, M.A., Patel, S.M., Mahamud, H.A., Kachienga, L.O., Kabue, J.P., and Potgieter, N. (2023). Isoniazid and rifampicin resistance-conferring mutations in South Africa. Pathogens, 12.","DOI":"10.3390\/pathogens12081015"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Mart\u00ednez, L.M., Chavelas-Reyes, J.L., Medina-Ram\u00edrez, C.F., Fuentes-Ch\u00e1vez, E., Mu\u00f1oz-Troncoso, Z.S., Estrada-Vega, \u00c1.G., Rodr\u00edguez-D\u00edaz, E., Torres-Morales, D., Moreno-Trevi\u00f1o, M.G., and Rodr\u00edguez-Gonz\u00e1lez, J.G. (2025). Molecular epidemiology of Mycobacterium tuberculosis in Mexico. Microorganisms, 13.","DOI":"10.3390\/microorganisms13112453"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Singh, A.K., Singh, N., Kumar, S., Mishra, A.K., and Singh, N.P. (2025). Molecular insights of drug-resistant tuberculosis. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1669327"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Nono, V.N., Nantia, E.A., Mutshembele, A., Teagho, S.N., Simo, Y.W., Takong, B.S., Djieugoue, Y.J., Assolo, Y.P., Ongboulal, S.M., and Awungafac, S.N. (2025). Prevalence of katG and inhA mutations. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-03816-9"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.2147\/IDR.S333433","article-title":"rpoB mutations and effects on rifampin resistance","volume":"14","author":"Li","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/ijmy.ijmy_101_23","article-title":"Whole-genome sequencing reveals genotypic resistance","volume":"12","author":"Hasan","year":"2023","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12941-024-00741-z","article-title":"Detection of multidrug-resistance by phenotype and molecular assays","volume":"23","author":"Decewicz","year":"2024","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"ofaf022","DOI":"10.1093\/ofid\/ofaf022","article-title":"Diagnostic accuracy of Xpert MTB\/XDR","volume":"12","author":"Pfurtscheller","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100466","DOI":"10.1016\/j.jctube.2024.100466","article-title":"Factors associated with tuberculosis drug resistance","volume":"37","author":"Okumu","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_17","first-page":"364","article-title":"Multidrug-resistant tuberculosis: Proactive strategies","volume":"30","author":"Nyasulu","year":"2024","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102570","DOI":"10.1016\/j.tube.2024.102570","article-title":"Combining bioinformatics and machine learning to identify diagnostic biomarkers of TB","volume":"149","author":"Ding","year":"2024","journal-title":"Tuberculosis"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Babirye, S.R., Nsubuga, M., Mboowa, G., Batte, C., Galiwango, R., and Kateete, D.P. (2024). Machine learning-based prediction of antibiotic resistance. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-10282-7"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Koura, K.G., Hashmi, S., Menon, S., Gando, H.G., Yamodo, A.K., Budts, A.-L., Meurrens, V., Lapelou, S.-C.S.K., Mbitikon, O.B., and Potgieter, M. (2025). Leveraging artificial intelligence to predict TB hotspots. Trop. Med. Infect. Dis., 10.","DOI":"10.3390\/tropicalmed10040093"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xu, C., Zhao, L.Y., Ye, C.S., Xu, K.C., and Xu, K.Y. (2025). The application of machine learning in clinical microbiology. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1545646"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2246","DOI":"10.7717\/peerj-cs.2246","article-title":"Predicting drug resistance using machine learning techniques","volume":"10","author":"Falcao","year":"2024","journal-title":"PeerJ Comput. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105887","DOI":"10.1016\/j.ijmedinf.2025.105887","article-title":"Comparing logistic regression and machine learning","volume":"199","author":"Boakye","year":"2025","journal-title":"Int. J. Med. Inform."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"van der Westhuizen, H.M., Giddy, J., Coetzee, R., Makanda, G., Tisile, P., Galloway, M., Bunyula, S., Schoeman, I., and Nathavitharana, R.R. (2024). Strengthening accountability for tuberculosis policy implementation in South Africa. BMC Glob. Public Health, 2.","DOI":"10.1186\/s44263-024-00077-y"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11136-025-03902-5","article-title":"The effects of stigma and social support on quality of life in drug-resistant TB","volume":"34","author":"Adejumo","year":"2025","journal-title":"Qual. Life Res."},{"key":"ref_26","unstructured":"Kipp, A.M., Olivier, D., Skonje, N., Majiza, L., Free, E., Preacher, K.J., Daftary, A., Ngcelwane, N., and Medina-Marino, A. (2025). Community variability in TB-related stigma in South Africa. medRxiv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/idr15040041","article-title":"Detection of mutations and genotyping of drug-resistant Mycobacterium tuberculosis strains","volume":"15","author":"Faye","year":"2023","journal-title":"Infect. Dis. Rep."},{"key":"ref_28","unstructured":"World Health Organization (2024). Global Tuberculosis Report 2024, WHO."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/jiad480","article-title":"Whole-genome sequencing predicting phenotypic drug resistance","volume":"229","author":"Tagami","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mboowa, G. (2025). Reimagining tuberculosis control in the era of genomics. Pathogens, 14.","DOI":"10.3390\/pathogens14100975"},{"key":"ref_31","unstructured":"World Health Organization (2025). WHO Consolidated Guidelines on Tuberculosis: Module 3\u2014Diagnosis, WHO."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e19112","DOI":"10.7717\/peerj.19112","article-title":"Development and validation of a nomogram predicting multidrug-resistant tuberculosis risk","volume":"13","author":"He","year":"2025","journal-title":"PeerJ"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/132\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:36:55Z","timestamp":1775623015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/4\/132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["diseases14040132"],"URL":"https:\/\/doi.org\/10.3390\/diseases14040132","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}